Why not make it 5 in a row? Right as the monkeypox hysteria is starting to grow, Chimerix sells its anti-pox asset. Looked like they only had 2 quarters of cash left, CEO said raising money can be difficult in current environment, in explaining the sale. The sell-first, think-later crowd inhabited the Chimerix-holding ranks, evidently. Chimerix makes ONC-201 and ONC-206, something sellers seem to have forgotten. Did monkeypox somehow get to their brains?
